Capsule Endoscopy in Patients with Cardiac Pacemakers and Implantable Cardioverter Defibrillators: (Re)evaluation of the Current State in Germany, Austria, and Switzerland 2010

Table 1

Results.

	Number of hospitals/outpatient clinics (𝑛=58)
Control of cardiac device before CE
Yes	16 (G)
No	34 (G =33, A/S = 1)
No reply to this question	8 (G = 7, A/S = 1)
Control of cardiac device after CE
Yes	28 (G = 27, A/S = 1)
No	27 (G = 26, A/S = 1)
No reply to this question	3 (G)
ECG during CE
Yes	29 (G = 28, A/S = 1)
No	24 (G)
No reply to this question	5 (G = 4,A/S = 1)
CE on ICU
Yes	8 (G = 7, A/S = 1)
No	47 (G)
No reply to this question	3 (G = 2, A/S = 1)
Disturbance of video
Yes	4 (G)
No	54 (G = 52, A/S = 2)
Interference of pacemaker/ICD
No	58
Arrhythmias
Yes	2 (G; SVES, VES)
no	56 (G = 54, A/S = 2)
Other complications
Yes	0
No	57 (G = 56, A/S = 1)
No reply to this question	1 (A/S)
Indication of CE
Bleeding	54 (G = 52, A/S = 2)
Inflammatory bowel disease	1 (G)
Other	2 (G)
No reply to this question	1 (G)
All (with und without application of CE, 𝑛=114)
Type of institution; (all G : 109, A/S : 5)
Hospital	82 (G = 78, A/S = 4)
Outpatient clinic	11 (G)
No reply to this question	21 (G = 20, A/S = 1)
Modification of application of CE
Yes	30 (G)
No	44 (G = 43, A/S = 1)
No reply to this question	40 (G = 36, A/S = 4)

CE: capsule endoscopy, ECG: electrocardiogram, ICU: intensive care unit, G: Germany, A: Austria, S: Switzerland.